| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | RADIUS HEALTH | 61,000 | 3,299,000 | 0.60% | ||
| 52 | Intersect ENT Inc | 205,325 | 3,252,000 | 0.59% | ||
| 53 | NEKTAR THERAPEUTICS COM | 186,000 | 3,195,000 | 0.58% | ||
| 54 | ULTRAGENYX PHARMACEUTICAL INC COM | 43,000 | 3,050,000 | 0.55% | ||
| 55 | NEUROCRINE BIOSCIE COM USD0.001 | 58,000 | 2,937,000 | 0.53% | ||
| 56 | MERCK & CO INC | 47,000 | 2,933,000 | 0.53% | ||
| 57 | LILLY ELI & CO | 35,000 | 2,809,000 | 0.51% | ||
| 58 | NOVADAQ TECHNOLOGIES INC | 230,000 | 2,661,000 | 0.48% | ||
| 59 | ANTHEM INC | 20,600 | 2,581,000 | 0.47% | ||
| 60 | THERMO FISHER SCIENTIFIC INC | 16,000 | 2,545,000 | 0.46% | ||
| 61 | QIAGEN NV | 91,500 | 2,511,000 | 0.45% | ||
| 62 | MACROGENICS INC | 83,000 | 2,483,000 | 0.45% | ||
| 63 | PROTHENA CORP PLC | 41,000 | 2,459,000 | 0.44% | ||
| 64 | ALKERMES PLC SHS | 51,500 | 2,422,000 | 0.44% | ||
| 65 | AGIOS PHARMACEUTICALS INC | 45,000 | 2,377,000 | 0.43% | ||
| 66 | HCA HOLDINGS INC | 31,200 | 2,360,000 | 0.43% | ||
| 67 | ZELTIQ AESTHETICS INCORPORATED | 60,000 | 2,353,000 | 0.43% | ||
| 68 | SEATTLE GENETICS INC | 43,000 | 2,322,000 | 0.42% | ||
| 69 | ANGIODYNAMICS INC | 130,000 | 2,280,000 | 0.41% | ||
| 70 | IMPAX LABORATORIES INC | 95,000 | 2,252,000 | 0.41% | ||
| 71 | INTERCEPT PHARMACEUTICAL | 13,500 | 2,222,000 | 0.40% | ||
| 72 | PROSHARES TR | 45,500 | 2,205,000 | 0.40% | ||
| 73 | HORIZON PHARMA PLC | 117,000 | 2,121,000 | 0.38% | ||
| 74 | EAGLE PHARMACEUTICALS INC COM | 29,000 | 2,030,000 | 0.37% | ||
| 75 | GLOBUS MED INC | 87,700 | 1,979,000 | 0.36% | ||
| 76 | BLUEBIRD BIO INCORPORATED | 29,000 | 1,966,000 | 0.36% | ||
| 77 | ACHILLION PHARMACEUTICALS INC COM | 240,000 | 1,944,000 | 0.35% | ||
| 78 | HUMANA | 10,800 | 1,910,000 | 0.35% | ||
| 79 | AETNA INC NEW | 16,400 | 1,893,000 | 0.34% | ||
| 80 | Wright Medical Group NV | 70,309 | 1,725,000 | 0.31% | ||
| 81 | PFIZER INC | 50,000 | 1,694,000 | 0.31% | ||
| 82 | ALNYLAM PHARMACEUTICALS INC | 24,000 | 1,627,000 | 0.29% | ||
| 83 | CLOVIS ONCOLOGY INC | 43,000 | 1,550,000 | 0.28% | ||
| 84 | HEALTHCARE SVCS GROUP INC COM | 38,100 | 1,508,000 | 0.27% | ||
| 85 | INOVIO PHARMACEUTICALS INC | 155,000 | 1,445,000 | 0.26% | ||
| 86 | ACADIA PHARMACEUTICALS INC COM | 45,000 | 1,431,000 | 0.26% | ||
| 87 | INSYS THERAPEUTICS INC NEW COM NEW | 115,000 | 1,356,000 | 0.24% | ||
| 88 | ALERE INC | 30,000 | 1,297,000 | 0.23% | ||
| 89 | BRISTOL MYERS SQUIBB CO | 23,000 | 1,240,000 | 0.22% | ||
| 90 | DIREXION DAILY S&P BIOTECH BULL 3X SHARES | 25,175 | 1,228,000 | 0.22% | ||
| 91 | JUNO THERAPEUTICS INCORPORATED | 37,000 | 1,110,000 | 0.20% | ||
| 92 | LABORATORY CORP AMER HLDGS | 8,000 | 1,100,000 | 0.20% | ||
| 93 | TELEFLEX INC | 6,500 | 1,092,000 | 0.20% | ||
| 94 | ALDER BIOPHARMACEUTICALS INC | 33,000 | 1,081,000 | 0.20% | ||
| 95 | MOLINA HEALTHCARE INC | 16,500 | 962,000 | 0.17% | ||
| 96 | ABBVIE INC | 15,000 | 946,000 | 0.17% | ||
| 97 | ENVISION HEALTHCARE HLDGS INC | 39,000 | 869,000 | 0.16% | ||
| 98 | CVS HEALTH CORP | 9,700 | 863,000 | 0.16% | ||
| 99 | QUOTIENT LTD | 110,000 | 860,000 | 0.16% | ||
| 100 | PORTOLA PHARMACEUTICALS INC | 36,000 | 818,000 | 0.15% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-021740, filed 2016.11.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
